Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
The current price of Merck & Co Inc in the market is 5 108,56 ₴, with a 24-hour trading volume of 12,24B ₴. The asset's market cap is 12,61T ₴, after moving -2.21% in the last day.
Tokenized Merck & Co Inc is trading at 5 136,74 ₴, with a tokenized market cap of 40,78M ₴ and a 24-hour trading volume of 40,81M ₴. The tokenized asset has moved 3.45% in the past 24 hours.